Los puntos clave no están disponibles para este artículo en este momento.
Abstract Despite progress understanding the costs and benefits of diversity in corporate boardrooms we continue to have many unanswered questions. As questions begin to be partially answered, more questions arise. Here I explore those layers of the boardroom diversity onion.
Amy J. Hillman (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: